I had seen the chart but it wasn’t until I was castigated on Twitter for not blogging about Vilacto Bio (VIBI) that I bothered to look into the promotion pushing it up. As is usual with promoted garbage stocks, the company has little in the way of assets ($135,000 per most recent 10-Q), no revenues, and negative book value.
There is a landing page promoting VIBI at: http://dailystocktraders.com/VIBI/
Disclosed budget: $2,000,000
Promoter: Dheise Oliveira / DailyStockTraders.com
Paying party: not mentioned
Shares outstanding: 90.000.000
Previous closing price: $1.67
Market capitalization: $150 million
Disclaimer from the landing page (emphasis mine):
Disclaimer: Information about many publicly traded companies, including Vilacto Bio Inc. and other investor resources can be found directly from the Securities and Exchange Commission as well as from its website, www.sec.gov. It is recommended that any investment in any security should be made only after consulting with your registered investment advisor and only after reviewing all publicly available information, including the statements of the company. Do not base any investment decisions upon any material found in this advertisement. The information contained herein has been prepared for informational purposes only and is not intended in any way to be used as a complete source of information on any particular company, including Vilacto Bio Inc. This publication does not purport to provide a full analysis of any company’s financial position. Any public company’s financial position and all other information regarding the company should be verified directly with the company and its regulatory disclosures. Dheise Oliveira has been paid $4,000 to be a spokesperson in this advertisement. An individual should not invest in the securities of Vilacto Bio Inc. based solely on information contained in this advertisement. Investing in securities is speculative and carries significant risk, including the total loss of principal. This advertisement is not intended to be, nor should it be construed as, an offer to buy or sell nor a solicitation to buy or sell securities, nor should it be construed as the provision of any investment related advice nor services tailored to any particular individual’s financial situation or investment objective(s). The publisher distributes general content offering impersonalized entertainment to readers and/or prospective readers and is not an investment advisor or broker-dealer registered with either the U.S Securities and Exchange Commission nor with any state securities regulatory authorities. The publisher is neither licensed nor qualified to provide financial advice. As such, the publisher rely upon the “publisher’s exclusion” as provided under Section 202(a)(11) of the Investment Advisors Act of 1940 and its corresponding state securities laws. Do not invest in this company unless you can afford to possibly lose your entire investment. The company featured herein appears as paid advertising, paid by a third party to provide public awareness for Vilacto Bio Inc. The publisher understands that in an effort to enhance public awareness of Vilacto Bio Inc. and its securities through the distribution of this online advertisement, if successful, the advertisement will increase investor and market awareness, which could result in increased numbers of shareholders owning and trading the common stock of Vilacto Bio Inc., and/or increase trading volumes, and/or possibly increased share price of the common stock of Vilacto Bio Inc. The publisher and marketing vendors will be managing a total budget of two million dollars, provided for all online advertising and marketing efforts; and will retain any amounts over and above the cost of production, advertising, copywriting services, mailing and other distribution expenses, as a fee for their services. The publisher has not undertaken to determine if paying parties are, or intend to be, directly or indirectly, a shareholder of Vilacto Bio Inc. This publication is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable; nevertheless, the publisher cannot guarantee the accuracy or completeness of the information. The information contained herein contain forward-looking information within the meaning of section 27a of the Securities Act and section 21e of the Securities Exchange Act including statements regarding expected growth of Vilacto Bio Inc. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act, the publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the Company’s actual results of operations. Factors that could cause actual results to differ include, but are not limited to, the size and growth of the market for the company’s products and services, the company’s ability to fund its capital requirements in the near and long term, pricing pressures and other risks detailed in the company’s filed reports with SEC. To the fullest extent of the law, we will not be liable to any person or entity for the accuracy, quality, completeness, reliability, or timeliness of the information provided herein, nor for any direct, indirect, consequential, incidental special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
PDF copy of landing page